AMGN.NASDAQAmgen INC

Form 4: Amgen Director Wanda M. Austin Reports Acquisition of 809 Shares Through RSU Vesting

Sentiment:

Insider Transaction Report


Amgen Inc. Director Wanda M. Austin has reported the acquisition of 809 shares of common stock through the vesting of Restricted Stock Units, increasing her beneficial ownership to 7,353 shares.

Summary

  • Wanda M. Austin, a Director of Amgen Inc. (AMGN), acquired 809 shares of common stock on May 23, 2025.
  • The acquisition was a result of the vesting of Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program and the Second Amended and Restated 2009 Equity Incentive Plan.
  • The RSUs vested immediately and were paid in shares of the Company's common stock on a one-to-one basis, with a transaction price of $0 per share.
  • Following this transaction, Ms. Austin beneficially owns a total of 7,353 shares of Amgen common stock.
  • Vested RSUs may be deferred by the director, with payment occurring according to an elected deferral schedule.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects a director increasing their stake in the company, albeit through compensation, which aligns their interests with shareholders. There are no negative implications from this routine filing.

Positives

  • The acquisition of shares by a director, even through RSU vesting, aligns the director's interests with those of the shareholders, indicating continued commitment to the company's performance.
  • The transaction is part of a pre-existing, approved incentive program, reflecting a structured approach to director compensation.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the vesting of Restricted Stock Units as part of director compensation. Such transactions are common across publicly traded companies as a standard method of aligning management and director interests with shareholders.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Program ReferenceThe transaction was conducted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. This highlights the existing framework for director equity compensation.05/23/2025Reinforces the company's established governance structure for director compensation, aligning director incentives with long-term shareholder value.

Related Party Transactions

  • The acquisition of shares by Director Wanda M. Austin through the vesting of Restricted Stock Units is a form of related-party transaction, representing compensation provided by the company to a member of its board of directors under an approved incentive program.

Stakeholder Impact

  • Shareholders: The transaction aligns the director's financial interests with those of the shareholders, as her beneficial ownership of common stock increases.
  • Employees: No direct impact on employees is indicated by this filing.

Key Dates

DateDescription
05/23/2025Date of transaction for the acquisition of 809 shares of common stock.
05/24/2025Date the Form 4 was signed by Wanda M. Austin.

Keywords

Amgen, AMGN, Wanda M. Austin, Form 4, SEC filing, insider transaction, stock acquisition, Restricted Stock Units, director compensation, equity incentive plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.